IRIS Tipologia: https://hdl.handle.net/10807/209 2026-07-14T18:50:30Z How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts https://hdl.handle.net/10807/342717 Titolo: How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts Autori: Mazzitelli M.; Serraino R.; Trecarichi E. M.; Murri R.; Torti C. 2026-01-01T00:00:00Z Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study https://hdl.handle.net/10807/342577 Titolo: Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study Autori: Cefalo, Jacopo; Varone, Francesco; Luppi, Fabrizio; Cameli, Paolo; Cerri, Stefania; Puci, Mariangela Valentina; Martini, Alessia; Franco, Giovanni; Zanini, Umberto; Pianigiani, Tommaso; Patsoura, Athina; Richeldi, Luca; Bargagli, Elena; Sotgiu, Giovanni; Mondoni, Michele Abstract: none 2026-01-01T00:00:00Z ASO Author Reflections: Beyond the Limits of Classic Hepatectomies: Ultrasound-Guided Parenchyma-Sparing Liver Resections https://hdl.handle.net/10807/342259 Titolo: ASO Author Reflections: Beyond the Limits of Classic Hepatectomies: Ultrasound-Guided Parenchyma-Sparing Liver Resections Autori: Giuliante F.; Famularo S. 2026-01-01T00:00:00Z Machine Learning-Based Treatment Allocation for Recurrent Hepatocellular Carcinoma - Reply https://hdl.handle.net/10807/342258 Titolo: Machine Learning-Based Treatment Allocation for Recurrent Hepatocellular Carcinoma - Reply Autori: Famularo S.; Donadon M.; Torzilli G. 2023-01-01T00:00:00Z